NCT00125294View on ClinicalTrials.gov

Sublingual Methadone for the Management of Cancer Breakthrough Pain

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

June 30, 2006

Study Completion Date

January 31, 2007

Conditions
CancerPain
Interventions
DRUG

Methadone

All Listed Sponsors
collaborator

Calgary Health Region

OTHER

lead

AHS Cancer Control Alberta

OTHER

NCT00125294 - Sublingual Methadone for the Management of Cancer Breakthrough Pain | Biotech Hunter | Biotech Hunter